Background: Respiratory viruses cause acute respiratory illness (ARI) in early childhood, but their effect on subsequent ARI admissions is not fully understood. This study aimed to determine the association between initial ARI admission because of viruses including human rhinovirus (HRV), respiratory syncytial virus (RSV), human adenovirus (HAdV) and human metapneumovirus (hMPV) and the risk of ARI readmission in children. Methods: Clinical information and nasopharyngeal swab samples were collected from children <2 years old at their initial ARI admission in Nha Trang, Vietnam, from January 2007 to April 2012. The incidence of ARI readmission during the follow-up period (initial admission to 5 years of age) was compared between children with and without 1 of 13 respiratory viruses (influenza virus A, influenza virus B, RSV, hMPV, parainfluenza virus-1, parainfluenza virus-2, parainfluenza virus-3 and parainfluenza virus-4, HRV, human coronavirus-229E, human coronavirus-OC43, HAdV and human bocavirus) at initial admission. Results: A total of 1941 children were enrolled in the study. Viruses were detected in 1254 (64.6%) children at enrollment; HRV, RSV, HAdV and hMPV were detected in 499 (25.7%), 439 (22.6%), 156 (8.0%) and 47 (2.4%) children, respectively. During the follow-up period (4572.7 personyears), 277 children were readmitted with ARI. Virus-related ARI initial admission was associated with an increased risk of ARI readmission for children who were initially admitted before 6 months of age (adjusted rate ratio, 1.6; 95% confidence interval: 1.1-2.5). HAdV (4.6; hMPV (20.4;) and HRV (1.6; 1.0-2.4) were independently associated with the outcome. These associations were not observed for children whose initial admission occurred after 6 months of age. Conclusions: HAdV-, hMPV-and HRV-related initial ARI admissions, when occurring during early infancy, increased the risk of subsequent ARIrelated readmission.
A cute respiratory illnesses (ARIs) are common and often recurrent in young children. A wide range of respiratory viruses, including respiratory syncytial virus (RSV), human rhinovirus (HRV), influenza virus A and B (Flu A and B), human adenovirus (HAdV), parainfluenza virus (PIV) and human metapneumovirus (hMPV), are associated with childhood ARIs such as bronchiolitis and pneumonia. [1] [2] [3] The risk of virus-related ARI is highest during early childhood and decreases with age. According to our previous study conducted in Vietnam, the annual incidence of virus-related ARI among children <24 months of age and 24-59 months of age was 65 per 1000 and 11 per 1000 person-years (PY), respectively. 4 The clinical presentation of ARI varies by virus. In Vietnam, infection with HRV, RSV and hMPV was found to be independent risk factors for severe ARI among children. 4 Virus-related ARIs in early childhood are also associated with subsequent respiratory problems. Previous studies have reported that RSV-related ARI increases the risks of subsequent wheezing, asthma and pneumonia in children. [5] [6] [7] Recent studies have shown that HRV-related wheezing is associated with recurrent wheezing and asthma in early childhood [8] [9] [10] and that hMPVrelated bronchiolitis in infancy is associated with an increased risk of asthma in children up to 5 years of age. 11 However, these studies did not systematically investigate the different effects of multiple viruses on later respiratory problems. Although the risk of viral infection differs by age, no study has investigated the potential changes in the impact of viral infection by timing of initial infection.
In the current study, utilizing our population-based ARI surveillance system in central Vietnam, we tested 13 respiratory viruses in young children admitted with ARI and investigated the effects of initial virus-related ARI admission on subsequent ARI admission. The effects were assessed by different viruses and by timing of initial ARI admission.
MATERIALS AND METHODS

Study Participants
The study was conducted at Khanh Hoa General Hospital in Nha Trang, central Vietnam. This hospital is the sole provider of secondary and tertiary care for children living in our catchment area (16 communes in Nha Trang). A population-based cross-sectional survey was conducted in 2006 that covered all residents of the catchment area (N = 198,000) 12 and was updated in 2010. ARI surveillance was initiated in January 2007. All children admitted to the hospital who (1) presented with cough and/or difficulty breathing; (2) were less than 60 months of age; and (3) resided in the catchment area were enrolled in the study. 13 Surveillance records were linked to census sociodemographic data by the unique census identification number.
For this study, we enrolled children <2 years of age who were admitted with ARI for the first time from January 29, 2007 , to April 20, 2012 (initial ARI admission). We investigated whether the enrolled children had died or left the catchment area by phone or home visit in 2013. Admission to the cohort began at the date of initial ARI admission and continued until the child was readmitted with ARI (main outcome), reached 5 years of age, died, left the area, or April 20, 2012 , whichever occurred first. The Institutional Review Boards at the National Institute of Hygiene and Epidemiology, Hanoi, and the Institute of Tropical Medicine, Nagasaki University, approved this study.
Variables
Clinical information, laboratory data and nasopharyngeal swab samples were collected from all enrolled ARI children soon after their admission. Multiplex polymerase chain reaction (PCR) assays were conducted to detect 13 respiratory viruses from the nasopharyngeal specimen (Flu A, Flu B, RSV, hMPV, PIV-1, PIV-2, PIV-3, PIV-4, HRV, human coronavirus-229E, human coronavirus-OC43, HAdV and human bocavirus). 14 The primers that were used in the multiplex PCR assay targeted RSV nucleoprotein and HRV noncoding region; thus, the PCR assays used in this study did not distinguish between different subtypes or genotypes.
Children were classified into 3 groups according to their age at enrollment: <6, 6-11 and 12-23 months. ARIs were classified as no pneumonia, pneumonia and severe pneumonia using modified algorithms from the World Health Organization Integrated Management of Childhood Illnesses. 15 The highest level of education for any household member was used as a household-level variable. Household economic status was modeled as a wealth index based on a previously applied principal component analysis of durable assets. 16 
Statistical Analysis
Baseline characteristics of the enrolled children were described by simple tabulations. The proportions of virus-positive cases at enrollment were compared between age groups using χ 2 test for trend. Readmission rates were compared between children who had tested positive for a specific virus at enrollment (viruspositive cohort) and those who had tested negative for all viruses (all virus-negative cohort). Readmission rate ratios (RRs) were estimated using Poisson regression analysis. Age, sex, type of ARI, presence of underlying diseases, household crowding, family smoking, wealth level and household educational level were considered potential confounders and were thus included in the multivariable Poisson regression models. Age was included as an age band to allow for aging by splitting the dataset according to current age. The dataset was further divided into calendar time bands according to current year. Confidence intervals (CIs) were adjusted for the clustering of communes using robust standard errors. Further details on definition of variables used in the multivariable model can be found in Detailed Methods, Supplemental Digital Content 1, http://links.lww.com/INF/D73.
Two sensitivity analyses were performed. In the first sensitivity analysis, cohort children whose residential status was unknown at the end of follow-up were excluded. In the second, children were allowed to enter cohorts every time that they were admitted for ARI during the study period. Viruses detected at each admission were considered the exposure, and the cohorts were stratified by age group at each time of admission. P values <0.05 were considered statistically significant. Statistical analyses were conducted using STATA version 12.0 (Stata Corp., College Station, TX.).
RESULTS
Characteristics of Participants at Enrollment
During the study period, 1948 children admitted with ARI were enrolled in the study, 7 of whom did not have viral data. After excluding these children, a total of 1941 participants were eligible for the analyses.
The baseline characteristics of the cohort children are shown in Table 1 . Subjects were mostly male (n = 1196, 61.6%), and the median age at enrollment was 11.5 months (interquartile range, 10.6). The total duration of follow-up was 4572.7 PY. During the follow-up period, 277 (14.3%) children were readmitted with ARI. The overall readmission rate was 60.6 per 1000 PY. The readmission rate decreased with age; the rate for children <6, 6-11 and 12-23 months of age at enrollment was 71.5, 63.7 and 53.4 per 1000 PY, respectively. The characteristics of children with and without readmission were similar.
Virus-positive Status at Enrollment
In total, 1254 (64.6%) children tested positive for at least 1 virus at enrollment ( Table 2) . HRV was the most common virus identified [n = 499 (25.7%)], followed by RSV [n = 439 (22.6%)] and Flu A [n = 201 (10.4%)]. HAdV and hMPV were detected in 156 (8.0%) and 47 (2.4%) children, respectively (Table 2) . Two or more viruses were identified in 19.5% of the virus-positive samples. RSV was identified more frequently in the younger age group (P < 0.001), while Flu A and HAdV were more frequently identified in the older age group (P < 0.001 and P < 0.001, respectively).
Effect of Initial Virus-related ARI Admission on ARI Readmission Rate
The readmission rates of cohort children according to infection with different viruses at enrollment are shown in Table 3 The readmission rate was higher among virus-positive children than all virus-negative children for those <6 months of age [adjusted RR (aRR), 1.61; 95% CI: 1.06-2.45], but the rates did not differ for those 6-11 months of age (aRR, 0.87; 95% CI: 0.63-1.19) or 12-23 months (aRR, 0.93; 95% CI: 0.61-1.41; Table 3 ). For the youngest age group, hMPV-related ARI admissions (aRR, 20.4; 95% CI: 6.22-66.87), HAdV-related ARI admissions (aRR, 4.6; 95% CI: 1.77-11.94) and HRV-related ARI admissions (aRR, 1.55; 95% CI: 1.01-2.39) independently increased the readmission rate (Table 3) . Other viruses such as RSV, Flu A and PIV3 were also associated with an increased risk of readmission, but their effects did not reach statistical significance. The effects were stronger for children 3-5 months of age at enrollment when we broke down the age group <6 months (Table, Supplemental Digital Content 2, http://links.lww.com/INF/D74). Viruses were not associated with readmission rates for children 6-11 or 12-23 months of age, with the exception of RSV, which was associated with a decreased risk of readmission for children 12-23 months of age. status had been confirmed at the end of follow-up (n = 1440) and found similar results (Table, Supplemental Digital Content 3, http:// links.lww.com/INF/D75). The findings were also similar when we allowed children to enter the cohort multiple times (a total of 2309 admissions, data not shown).
DISCUSSION
Virus-related ARI admission was associated with an increased risk of ARI readmission among young children who were less than 6 months of age at their initial admission. However, this association was not observed among children whose initial admission occurred after they were 6 months of age. The effect of virus-related ARI admission on ARI readmission rate differed by virus: hMPV showed the strongest effect, followed by HAdV and HRV. Thus, the effect of virus-related ARIs on later ARI by virus and timing of infection was systematically and comprehensively demonstrated.
Mid-and Long-term Effects of Virus-related ARI
Studies have shown that virus-related ARI in early childhood is associated with both mid-and long-term respiratory problems, such as asthma and pneumonia. Singleton et al. 6 showed that RSV infection in children <2 years of age increased the risks of wheezing, lower respiratory infections and asthma until children were 4 years of age. Jackson et al. 9 showed that HRV-related wheezing was associated with further wheezing and asthma in early childhood. On the other hand, a study conducted by Cox et al. 17 failed to demonstrate an association between RSV and subsequent hospital respiratory admissions.
Our findings suggested that the mid-term effect of virusrelated ARI admission differed by the timing of initial infection. We found that initial virus-related ARI admission when it occurred before 6 months of age increased the risk of ARI readmission. The effect was substantial when a child had initial virus-related ARI admission at 3-5 months of age; however, the sample size was too small to evaluate the effect for the younger age group (ie, <3 months). The strong effect of virus-related ARI observed in 3-5 months of age may be related to the immune system during this period. It has been reported that during this period, maternal immunoglobulins are reducing and own immunoglobulin production is still not optimal. 18 Virus infection during this period may induce inflammation in the airways which may result in deleterious changes in respiratory function and manifest as persistent wheezing and/or asthma. 19 It also may not elicit a sufficient immune response and this partial immunity may increase the risk of subsequent infection. 20 However, we could neither measure immunoglobulins nor perform a subanalysis on ARI readmission with wheezing/asthma as an outcome because we could not distinguish it from all ARI admissions in this study because of the limited clinical information. These factors should be examined and investigated in future studies. We also tried to explore other factors as a potential effect modifier surrogating the age group: nutritional status, prematurely born and coinfection. Number of children with malnutrition reported by parent were too small for further analysis, 1, 5 and 3 in age group <6, 6-11 and 12-23 months, respectively. There were no other indicators of nutritional status and record of prematurely born available in the research setting. Viral codetection rates in virus-positive children were 15%, 19% and 22% in age group <6, 6-11 and 12-23 months, respectively, and the readmission rate among children with viral codetection did not differ from those with single viral detection (aRR, 1.07; 95% CI: 0.74-1.56). Bacterial coinfection could not be evaluated because blood culture was not performed routinely on hospitalized ARI cases in the study hospital; however, mean of white blood cell count as an indicator of bacterial infection was 11.1 × 10 3 /μL (standard deviation: 4.1), 13.4 (5.6) and 13.9 (7.6), respectively. Therefore, coinfection was less likely to derive difference of the effect of initial virus-related ARI admission on ARI readmission in each age group. 
Virus-specific Effects
Regarding virus-specific effects, hMPV showed the strongest effect on the risk of ARI readmission. In Spain, García-García et al. 11 recruited children who had been admitted with and without hMPV-related bronchiolitis in the first 2 years of life and compared their frequencies of wheezing at 3 and 5 years of age. They found that hMPV-related bronchiolitis was strongly associated with later development of asthma (odds ratio, 15.9). Although our primary outcome was ARI readmission, not asthma, our observations can be considered as complementary to their findings. hMPV infection has been strongly associated with lower respiratory infection among young children, 4 and its damage to respiratory functions may persist for several years.
In the current study, HRV-related ARI admission before 6 months of age was associated with subsequent ARI admission. Previous studies have also reported that HRV-related ARI in early childhood is associated with recurrent wheezing. [8] [9] [10] Recently, HRV-A and HRV-C species have been shown to cause more severe respiratory illnesses than HRV-B in infants. 21 Cox et al. 17 showed that HRV-C-related wheezing illnesses in children younger than 5 years of age were associated with an increased risk of subsequent hospital respiratory admissions within 12 months. Our results seem consistent with their findings; however, further HRV species-specific analysis will be required to clarify a more detail effect of HRV.
We also made the original observation that HAdV-related ARI admission increased the risk of ARI readmission. HAdV infection is common in childhood ARIs: HAdV has been associated with 6%-8% of ARIs in children younger than 5 years old. 4, 22 However, the epidemiology of HAdV-related respiratory infections is not fully understood. Further studies are needed to establish the effects of HAdV infection on the respiratory system.
In this study, RSV-related ARI admission did not affect the risk of ARI readmission. Previous studies have found an association between RSV-related lower respiratory tract infection and long-term respiratory morbidity, including recurrent wheeze and asthma. 5, 6, [23] [24] [25] [26] However, some studies have failed to demonstrate this association. Cox et al. 17 reported that compared with other viruses, RSV was associated with a decreased risk of subsequent respiratory admissions, whereas the rate of readmission for pneumonia in RSV-related lower respiratory infections did not differ from that of non-RSV lower respiratory infections in a study by Munywoki et al. 7 Our finding could be explained by an acquisition of protective immunity against RSV infection resulting from the initial infection. In fact, RSV-related ARI admission was associated with a decreased risk of readmission for RSV-related ARI (aRR, 0.47; 95% CI: 0.19-1.13), and this association was particularly strong among children 12-23 months of age (aRR, 0.14; 95% CI: 0.02-0.82; data not shown in results). This finding may suggest that RSV immunity acquired from the index RSV infection reduced subsequent RSV infection and that the immunity was stronger when the index infection occurred after infancy. RSV infection induces mucosal and systemic virus-neutralizing antibody responses and cell-mediated responses, and secretory and serum antibodies play the primary role in protection against reinfection. However, with the exception of passively acquired RSV-neutralizing antibodies, the correlates of protection in young infants are difficult to measure and are poorly understood. 27 In this study, RSV genotype information was not available and we were not able to conduct RSV genotype-specific analysis; however, this does not change the overall role of RSV on pediatric ARI readmission.
Implication of the Study Findings
Our findings suggest that young infants with virus-related ARI, especially those with hMPV-, HRV-and HAdV-related ARI, require careful follow-up until they are at least 5 years of age because of their increased risk of readmission. Rapid diagnostic tests for hMPV and HAdV may be useful for improving the clinical management of these children. Studies using hMPV proteins as subunit vaccine candidates and recombinant/nonrecombinant liveattenuated viruses have recently been conducted. 28, 29 Additionally, inactivated and live-attenuated HRV vaccine candidates have been studied using animal models and human trials. 30 Once these vaccines become available, they are expected to reduce the risk of ARI admission and subsequent ARI-related readmission. Furthermore, as the subsequent effect of these viruses was observed only during early infancy, a cocoon immunization strategy might be a preferable option.
Limitations
This study has limitations. First, to estimate the effect of virus-related ARI admission on our primary outcome, we analyzed cohort children who had tested negative for all viruses as a reference. Although we systematically screened for 13 viruses, this group may have included other pathogens that were not assessed such as enteroviruses 31 and bacteria, potentially leading to an underestimation of the true effect of viruses. Second, we conducted this study using a hospital-based surveillance system and did not conduct regular follow-ups of our cohort children in the community. This method may have introduced selection and measurement bias. However, our study hospital is the sole provider of admission care for residents in the area, and it is less likely that children with ARI who require admission care would have been missed in our study, as the free national insurance for all children up to 6 years of age in Vietnam facilitated good access to hospital care. We also performed a sensitivity analysis that excluded children with an unknown residential status, and the findings did not substantially differ from the original results. Therefore, we believe that the impact of selection bias was minimal. Third, we only considered children with ARI who required hospitalization. Consequently, our findings may not be generalizable to all virus-related mild or asymptomatic ARI cases. Fourth, we did not perform HRV and RSV species or subgroup/genotype testing, so we were not able to analyze HRV and RSV species or subgroup/genotype-specific effect. However, this does not change our study finding and we hope to clarify it in a future study.
CONCLUSIONS
Virus-related ARI admission among young infants increased the risk of ARI readmission in children up to 5 years of age. A substantial effect was observed for hMPV-, HRV-and HAdV-related ARI admissions in particular. Our findings suggest that the use of diagnostic tests and new vaccines to manage these viruses may improve children's mid-term or long-term health outcomes.
